Clinical Implications of Pharmacokinetics and Pharmacodynamics of Fluoroquinolones
Open Access
- 15 July 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (Supplement) , S127-S135
Abstract
This review summarizes key data illustrating the clinical importance of pharmacodynamics, particularly among the fluoroquinolone family of antibacterKeywords
This publication has 52 references indexed in Scilit:
- Pharmacodynamics of Levofloxacin and Ciprofloxacin in a Murine Pneumonia Model: Peak Concentration/MIC versus Area under the Curve/MIC RatiosAntimicrobial Agents and Chemotherapy, 2003
- AUC0-t/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection modelJournal of Antimicrobial Chemotherapy, 2003
- Activities of Moxifloxacin against, and Emergence of Resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an In Vitro Pharmacokinetic ModelAntimicrobial Agents and Chemotherapy, 2003
- Worldwide Antimicrobial Susceptibility Patterns and Pharmacodynamic Comparisons of Gatifloxacin and Levofloxacin against Streptococcus pneumoniae : Report from the Antimicrobial Resistance Rate Epidemiology Study TeamAntimicrobial Agents and Chemotherapy, 2003
- Contribution of the 8-Methoxy Group to the Activity of Gatifloxacin against Type II Topoisomerases of Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2003
- Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection ModelsAntimicrobial Agents and Chemotherapy, 2002
- Propensity of Fluoroquinolones with Different Moieties at Position 8 to Cause Resistance Development in Clinical Isolates of Streptococcus pneumoniae Antimicrobial Agents and Chemotherapy, 2001
- Pharmacodynamic Assessment of Gatifloxacin against Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- Fatal Meningitis Due to Levofloxacin-Resistant Streptococcus pneumoniaeClinical Infectious Diseases, 1999
- Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporinsDiagnostic Microbiology and Infectious Disease, 1995